Literature DB >> 8737389

Enteric pathogens associated with gastrointestinal dysfunction in children with HIV infection.

A G Ramos-Soriano1, J M Saavedra, T C Wu, R A Livingston, R A Henderson, J A Perman, R H Yolken.   

Abstract

Infants and young children with HIV infection commonly suffer from gastrointestinal manifestations of their disease. Many HIV infected children have evidence of persistent diarrhoea, malabsorption, malnutrition or growth failure. The aetiology and pathogenesis of gastrointestinal dysfunction in HIV infected children have not been well defined. We performed immunocytochemical analyses on intestinal tissue from 19 HIV-infected children with gastrointestinal dysfunction or growth failure. None of these 19 children had microbial pathogens identified in faecal samples using standard microbiological methods. Intestinal tissues were obtained from the children by biopsy and were examined for antigens from Pneumocystis carinii, cytomegalovirus (CMV) and herpes simplex virus (HSV) using the avidin-biotin-complex immunohistochemical technique and monoclonal or monospecific antibodies. We detected at least one of these pathogens in samples from eight (42%) of 19 HIV infected children. P. carinii was the most prevalent pathogen, found in five of the eight HIV infected children. All of the children with intestinal pneumocystis infection were receiving prophylaxis directed at the prevention of pulmonary disease with this organism and none of them were undergoing active pulmonary infection. We also identified CMV antigens in intestinal tissues from four children and HSV antigens in intestinal tissues from one child. Two children were infected with more than one pathogen. On the other hand, none of these pathogens were found in the tissues obtained from 10 HIV-uninfected patients who had intestinal tissues obtained for chronic non-infectious diarrheal and inflammatory diseases (P < 0.01, Fisher's exact test). Our findings indicate that some children with HIV infection and gastrointestinal dysfunction may be infected with opportunistic pathogens despite negative analyses employing standard microbiological methods. Our study also indicates that HIV infected children can undergo intestinal infection with P. carinii despite the administration of standard immunoprophylactic regimens directed at the prevention of infection with this organism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8737389     DOI: 10.1006/mcpr.1996.0010

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  6 in total

Review 1.  Management of gastrointestinal disorders in children with HIV infection.

Authors:  Alfredo Guarino; Eugenia Bruzzese; Giulio De Marco; Vittoria Buccigrossi
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 2.  Impact of antiretroviral therapy on growth, body composition and metabolism in pediatric HIV patients.

Authors:  Roy J Kim; Richard M Rutstein
Journal:  Paediatr Drugs       Date:  2010-06       Impact factor: 3.022

Review 3.  Prevalence of intestinal pathogens in HIV patients with diarrhea: implications for treatment.

Authors:  B S Ramakrishna
Journal:  Indian J Pediatr       Date:  1999 Jan-Feb       Impact factor: 1.967

4.  Enteric virus infections and diarrhea in healthy and human immunodeficiency virus-infected children.

Authors:  M B Liste; I Natera; J A Suarez; F H Pujol; F Liprandi; J E Ludert
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 5.  Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings.

Authors:  Surbhi Modi; Alex Chiu; Bernadette Ng'eno; Scott E Kellerman; Nandita Sugandhi; Lulu Muhe
Journal:  AIDS       Date:  2013-11       Impact factor: 4.177

Review 6.  Treatment interventions for diarrhoea in HIV-infected and HIV-exposed children: a systematic review.

Authors:  Nkengafac Villyen Motaze; Chukwuemeka Nwachukwu; Eliza Humphreys
Journal:  Pan Afr Med J       Date:  2018-04-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.